Long-term outcomes of atezolizumab-bevacizumab in unresectable hepatocellular carcinoma: A real-world study.

Journal:

Hepatology

Published:

2026-02-27

DOI:

10.1097/hep.0000000000001725

Affiliations:

32

Authors:

28

Go to article

Institutions	Authors	Share
Sant'Orsola Malpighi Hospital, Italy	3.000000	0.11
University Hospital of Pisa, UNIPI, Italy	2.000000	0.07
IRCCS Istituto Oncologico Veneto (IOV), Italy	2.000000	0.07
IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Italy	1.500000	0.05
IRCCS Humanitas Research Hospital, Italy	1.500000	0.05
University of Florence (UNIFI), Italy	1.500000	0.05
University of Palermo (UP), Argentina	1.333333	0.05
Ospedale del Mare, Italy	1.000000	0.04
University of Foggia (UNIFG), Italy	1.000000	0.04
University Hospital of Verona, Italy	1.000000	0.04
University of Verona (UNIVR), Italy	1.000000	0.04
University of Bologna (UNIBO), Italy	1.000000	0.04
Azienda Ospedaliero Universitaria Ospedali Riuniti - Foggia, Italy	1.000000	0.04
Azienda Unità Sanitaria Locale della Bologna (AUSL Bologna), Italy	1.000000	0.04
Catholic University of the Sacred Heart (UCSC), Italy	1.000000	0.04
Ospedale degli Infermi di Faenza, Italy	1.000000	0.04
Agostino Gemelli University Polyclinic, Italy	1.000000	0.04
Marche Polytechnic University (UNIVPM), Italy	1.000000	0.04
Niguarda Hospital, Italy	1.000000	0.04
Careggi University Hospital (AOUC), UNIFI, Italy	0.500000	0.02
University of Udine (UNIUD), Italy	0.500000	0.02
Azienda sanitaria universitaria Friuli Centrale (ASU FC), Italy	0.500000	0.02
University of Milan (UNIMI), Italy	0.500000	0.02
Humanitas University, Italy	0.500000	0.02
Hammersmith Hospital, Imperial College Healthcare NHS Trust, United Kingdom (UK)	0.333333	0.01
Imperial College London (ICL), United Kingdom (UK)	0.333333	0.01

Interested in Oncology and Carcinogenesis?